Guinness Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-23
Closed -$5K – 104
2019
Q1
$5K Hold
23
– – ﹤0.01% 102
2018
Q4
$7K Buy
23
+3
+15% +$957 ﹤0.01% 92
2018
Q3
$7K Hold
20
– – ﹤0.01% 92
2018
Q2
$6K Hold
20
– – ﹤0.01% 94
2018
Q1
$5K Hold
20
– – ﹤0.01% 97
2017
Q4
$6K Hold
20
– – ﹤0.01% 91
2017
Q3
$6K Hold
20
– – ﹤0.01% 94
2017
Q2
$5K Hold
20
– – ﹤0.01% 99
2017
Q1
$5K Hold
20
– – ﹤0.01% 94
2016
Q4
$6K Buy
+20
New +$5.93K ﹤0.01% 89

Other funds holding BIIB

Guinness Asset Management's BIIB Position: Q2 2019 in Review

Guinness Asset Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 23 shares — an estimated $5K sold.

Guinness Asset Management first reported a position in BIIB in Q4 2016 and held it in 10 quarters. The position peaked at $7K in Q4 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Guinness Asset Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Guinness Asset Management sold 23 Biogen shares in Q2 2019, an estimated $5K.
  • Guinness Asset Management first reported a position in Biogen in Q4 2016 and held it in 10 quarters.
  • Guinness Asset Management's Biogen position peaked at $7K in Q4 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Guinness Asset Management's 13F filing for Q2 2019, filed 26 Jul 2019.